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Abstract
Despite a large number of evidence-based health communication interventions tested in private, 
public, and community health settings, there is a dearth of research on successful secondary 
dissemination of these interventions to other audiences. This article presents the case study of 
“1-2-3 Pap,” a health communication intervention to improve human papillomavirus (HPV) 
vaccination uptake and Pap testing outcomes in Eastern Kentucky, and explores strategies used to 
disseminate this intervention to other populations in Kentucky, North Carolina, and West Virginia. 
Through this dissemination project, we identified several health communication intervention 
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design considerations that facilitated our successful dissemination to these other audiences; these 
intervention design considerations include (a) developing strategies for reaching other potential 
audiences, (b) identifying intervention message adaptations that might be needed, and (c) 
determining the most appropriate means or channels by which to reach these potential future 
audiences. Using “1-2-3 Pap” as an illustrative case study, we describe how careful planning and 
partnership development early in the intervention development process can improve the potential 
success of enhancing the reach and effectiveness of an intervention to other audiences beyond the 
audience for whom the intervention messages were originally designed.
Recently, the National Institutes of Health (NIH), the Agency for Healthcare Research and 
Quality (AHRQ), the Centers for Disease Control and Prevention (CDC), and other national 
agencies such as the Patient Centered Outcomes Research Institute (PCORI) and U.S. 
Department of Veterans Affairs have focused their attention on the practice of designing 
public health interventions for effective dissemination and implementation (D&I) to 
influence health behavior (Brownson, Dreisinger, Colditz, & Proctor, 2012; Meissner et al., 
2013). This increased attention reflects growing recognition among researchers and medical 
professionals that advances in intervention research are limited by the failure to translate 
evidence-based research findings into practice (Glasgow & Emmons, 2007).
Clearly, secondary dissemination of successful interventions is crucial to improving health 
and disease prevention outcomes (Meissner et al., 2013). Broader secondary dissemination 
occurs when researchers consider how to spread evidence-based interventions to other 
audiences or via other channels using planned strategies. To facilitate broad dissemination, 
Rabin, Brownson, Haire-Joshu, Kreuter, and Weaver (2008) argue that dissemination 
researchers should identify “processes and factors that lead to widespread use of an 
evidence-based intervention” (p. 118). Medically underserved populations potentially can 
benefit from previously developed evidence-based interventions, as the use of existing 
interventions eliminates the need for the time-and resource-consuming tasks involved with 
intervention development and evaluation that may not be available to those working with 
underserved populations. In addition, researchers tangentially benefit from intervention 
dissemination because they can replicate their study designs with different populations, 
employing different media and different settings and thereby providing further evidence of 
their interventions' effectiveness in improving health outcomes.
However, successful dissemination of interventions can face a variety of challenges. Among 
the most commonly cited reasons public health practitioners do not adopt evidence-based 
interventions are conflicting mandates, funding limitations, workforce capacity issues, 
doubts about intervention efficacy in their practice contexts, and cost concerns (Bekemeier, 
Chen, Kawakyu, & Yang, 2013; Sosnowy, Weiss, Maylahn, Pirani, & Katagiri, 2013). 
Indeed, dissemination of evidence-based health interventions in clinical and public health 
contexts may require very tailored approaches, given wide variance in organizational 
governance structures, funding sources, and mandates (Mays, 2011). In addition, in the 
communication literature, research designs often involve identifying specific channels, using 
planned strategies, and conducting audience research to design effective, targeted messages 
for a particular audience. This specificity in research design creates a situation in which 
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dissemination of the intervention to other populations—who may have differing access to 
media channels, be characterized by different salient audience attributes and demographics, 
and require different strategies for effective intervention delivery—is a potentially difficult 
task.
In order to maximize the reach, effectiveness, and value of evidence-based interventions, it 
is essential that health communication researchers and those with whom they work consider 
in advance the ways in which these programs may be disseminated to other populations. 
Specifically, at the early stage of intervention design, designers should consider (a) what 
types of organizations and communities are most likely to adopt health communication 
programs and the additional potential target audiences for the intervention, (b) adaptations 
that might be needed to target the message characteristics of the intervention to these future 
audiences, and (c) strategies or media channels for reaching these audiences. To illustrate 
the importance of these three concerns, we present a case study of the development of the 
“1-2-3 Pap” intervention in eastern Kentucky and the dissemination strategies used to 
partner with two public health Practice-Based Research Networks (PBRNs) and the West 
Virginia Immunization Network to implement the intervention with new target audiences 
and in diverse practice settings.
BACKGROUND: DEVELOPMENT OF THE “1-2-3 PAP” INTERVENTION
The foundation for the “1-2-3 Pap” intervention was built through extensive research and 
partnerships with community members. The CDC-funded Rural Cancer Prevention Center 
(RCPC), which focuses on cancer issues is Appalachian Kentucky, identified how young 
women living in Appalachian Kentucky were significantly less likely than their urban 
counterparts to receive dose 1 of the human papillomavirus (HPV) vaccine and to follow up 
with doses 2 and 3, even when the vaccine was offered free of charge (Crosby, Casey, 
Vanderpool, Collins, & Moore, 2011). RCPC researchers then conducted formative work 
exploring knowledge, attitudes, facilitators, and barriers to both Pap testing and HPV 
vaccination among local healthcare providers and young women living in Appalachian 
Kentucky (Cohen & Head, 2013; Head & Cohen, 2012; Head, Vanderpool, & Mills, 2013). 
On the basis of this formative research and community engagement, the RCPC designed the 
“1-2-3 Pap” video-based cervical cancer prevention intervention, which aimed to improve 
HPV vaccination uptake and adherence rates and guideline-appropriate Pap testing among 
young adult women aged 18 to 26 years living in Appalachian Kentucky (Cohen et al., 2013; 
Vanderpool, Cohen et al., 2013).
In consultation with the RCPC's Community Advisory Board, the “1-2-3 Pap” intervention 
was launched in 2010 in a medically underserved, economically distressed region of 
Appalachian Kentucky. Participants in the intervention were recruited into the study in local 
health departments, clinics, and community locations such as colleges, outdoor festivals, and 
local retail stores (Cohen et al., 2013). Medically and age-eligible young women first were 
provided with dose 1 of the HPV vaccine series free of charge (N = 344) and then asked to 
participate in a research study wherein enrolled participants were randomly assigned to 
either the intervention arm (n = 178) or the usual-care comparison arm (n = 166; Vanderpool 
et al., 2013). Women assigned to the intervention arm watched the 13-minute “1-2-3 Pap” 
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video, which consisted of messages about the importance of HPV vaccination and Pap 
testing. Design and development of the video was guided by the integrated behavioral model 
(Montaño & Kasprzyk, 2008) and the information-motivation-behavioral skills model 
(Fisher, Fisher, & Harman, 2003; Fisher, Fisher, & Shuper, 2009). The video featured a 
local female television news anchor, local health care providers (a nurse and a physician), 
and young women from the Appalachian community where the intervention took place. 
Women in both the intervention and comparison arms received follow-up calls from the 
local RCPC research nurses to remind them about completing doses 2 and 3 of the HPV 
vaccine series, the primary outcome of the research study. Findings indicated that the 
intervention was effective in improving vaccine adherence, as nearly half of the women 
(43.3%) randomized to the intervention arm completed the 3-dose series and only 31.9% of 
women assigned to the usual-care comparison group completed the series (percent relative 
difference of 35.7% [p = .03]; Vanderpool, Cohen et al., 2013). In adjusted analysis, women 
assigned to the “1-2-3 Pap” intervention were almost 2.5 times more likely than women in 
the usual-care group to complete the HPV vaccine series (p = .001; Vanderpool, Cohen et 
al., 2013). For a more thorough description of the “1-2-3 Pap” efficacy study, see Cohen et 
al. (2013) and Vanderpool, Cohen et al. (2013).
ADDRESSING THREE KEY DISSEMINATION CONCERNS RELATED TO 
“1-2-3 PAP”
The initial success of “1-2-3 Pap” in Appalachian Kentucky coupled with formative research 
with a broader population of Kentucky women (Cohen & Head, 2013; Cohen et al., 2013) 
demonstrated to the RCPC team that, with minor modifications, the intervention potentially 
could be retargeted for dissemination to other audiences. However, redeveloping the video 
for dissemination to other audiences beyond the initial target population required reconciling 
the tension between designing a targeted communication intervention based on extensive 
formative work with a specific population (i.e., our original “1-2-3 Pap” intervention in 
Appalachian Kentucky) and identifying other potential target audiences and delivery 
contexts for which the intervention would be appropriate. A second concern was identifying 
specific changes to the intervention message, such as modifications to the message source 
and content, which might be needed in disseminating the intervention to other audiences. A 
third concern was how to select and optimize effective means for reaching these potential 
future target audiences via distinct message delivery channels. In the sections that follow, 
we discuss these concerns and how the RCPC addressed them by partnering with three 
practice-based organizations: the Kentucky Public Health Research Network (KePHRN), the 
North Carolina Public Health Practice-Based Research Network (NC PBRN), and the West 
Virginia Immunization Network (WIN).
Concern 1: Identifying Additional Dissemination Contexts and Target Audiences
In planning in advance for dissemination of an intervention, a critical aspect of the 
intervention development process is identifying new contexts for dissemination and 
potential partners who can provide access to these other audiences (Bernhardt, Mays, & 
Kreuter, 2011). In order to do so, researchers must systematically plan to disseminate the 
intervention through a variety of methods to potential users. In addition to gaining the 
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support of potential users in the field, researchers must work to eliminate financial barriers 
to dissemination partnerships in dissemination planning (Viswanath & Kreuter, 2007). To 
address financial barriers in the context of the “1-2-3 Pap” intervention, first, the lead author 
secured university pilot funding to develop an initial adaptation of the video for statewide, 
general audiences. Securing such pilot funding allowed the research team to plan to extend 
the “1-2-3 Pap” intervention from the Appalachian Kentucky catchment area to create an 
adaption appropriate for a statewide audience and audiences in other similar states. This 
pilot adaptation involved altering message content to make a version appropriate for 
audience members who might not have had the first dose of the HPV vaccine and who were 
not from the Appalachian region of the state. The RCPC then asked Kentucky public health 
officials to help share both the original and the adapted video with potential partners to 
view. Although many researchers view such deviation from the initial intervention to be 
problematic, there are good reasons for iterative design of the intervention after researchers 
reflect on the success and limitations of the initial intervention design (Hecht & Miller-Day, 
2010; we address these reasons for adaptation coinciding with dissemination later, as 
concern 2). In the Kentucky context, it was clear that adaptation would help us secure 
additional natural state and local partners who had heard about the initial intervention and 
who expressed interest in a revised video appropriate for all young adult female audiences. 
Thus, one important and over-arching design principle is that researchers reorient their 
design efforts to the needs of potential users and audiences (including considering new types 
of information in the format and languages appropriate to new potential audiences) rather 
than the planned initial intervention audience.
Researchers should proactively identify new audiences and specific possible 
partners that seem plausible—For example, researchers may proactively define and 
identify intervention goals and associated messages that potential new audiences have 
identified as important to them. In the case of HPV immunization, potential partners were 
interested in improving HPV immunization rates in their community's young adult female 
population and in developing strategies to improve adherence to the three-dose HPV vaccine 
schedule. By showing the intervention script and discussing the intervention with public 
health officials in Kentucky, the research team identified three potential new audiences: 
young adults who had not received the first dose of the vaccine who were 21–40 years old, 
adolescent girls (9–21 years old), and young men (for whom the vaccine manufacturers were 
seeking a federal recommendation). However, because the latter two audiences were not 
appropriate for receiving the core intervention message (that three doses of HPV vaccine 
and Pap testing are critical to cervical cancer prevention), we identified this first closely 
related audience's information needs early on as the most likely additional target for 
dissemination planning. The other two audiences offered potential areas for new research as 
targets for new, different intervention designs.
Another proactive component to developing partnerships for dissemination of “1-2-3 Pap” 
involved describing and championing the intervention at various conferences, meetings, 
webinars, and other venues where potential partners from a variety of disciplines and 
professional backgrounds were present. Personal marketing by researchers through 
professional associations, seminars and workshops, e-mail alerts, and journal articles is a 
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critical step to help potential other partners see the potential utility of dissemination for their 
context and audience (Brownson, Jacobs, Tabak, Hoehner, & Stamatakis, 2013).
To this point, RCPC researchers promoted the “1-2-3 Pap” intervention at regional 
immunization education and health conferences and encouraged those attending the 
conferences to consider similar strategies with populations in their own service areas. By 
having representatives of this Appalachian eastern Kentucky intervention address the West 
Virginia Immunization Network (WIN) annual conference, researchers became personal 
champions for their intervention at a natural potential site for dissemination, given the 
shared interest in improving immunization outcomes in an Appalachian population. With 
resources to invest in an adaptation of the initial intervention appropriate to its Appalachian 
audience (whose demographics and psychographics are similar to those of the original 
“1-2-3 Pap” Appalachian Kentucky target audience), the WIN became a natural 
dissemination adaptation partner and offered a second dissemination opportunity with a 
similar target audience. Furthermore, the WIN was willing to coordinate and champion 
dissemination to an established network of health educators, researchers, and clinicians who 
might want to use the adapted “1-2-3 Pap” intervention with their patient populations.
Researchers should look for opportunities to address multiple potential 
partners simultaneously—As the WIN partnership succeeded as a pilot project, RCPC 
researchers simultaneously sought other opportunistic partners for dissemination and 
presented the “1-2-3 Pap” intervention to 24 public health PBRNs at the National 
Coordinating Center for Public Health PBRNs' 2013 Annual Grantee Meeting (for 
information, see http://www.publichealthsystems.org/keeneland-2013.aspx). These public 
health PBRNs provide a promising avenue for translational collaborations (Mays, Hogg, 
Castellanos-Cruz, Hoover, & Fowler, 2013; Vanderpool, Brownson, Mays, Crosby, & 
Wyatt, 2013). In existence since 2008, the public health PBRN program brings practitioners 
from state and local health departments together with academic researchers to identify, 
study, and solve research problems that have real-world relevance (Mays, 2011). Public 
health PBRN projects focus on identifying the most effective and efficient means of 
organizing, financing, and delivering public health services, often in relation to the Public 
Health Services and Systems National Research Agenda (Scutchfıeld, 2012). A subset of 
research priorities within this agenda's Public Health Information and Technology domain 
directly addresses improving the translation and dissemination of evidence-based public 
health strategies into practice, making PBRNs ideal dissemination partners for this project.
Interested PBRNs were invited to sign up for additional information, with eight networks 
expressing initial enthusiasm for the project. A series of planning calls followed in which 
collaborative research designs were developed and networks evaluated their capacities to 
participate. Ultimately, two public health PBRNs—Kentucky and North Carolina—self-
selected into the study, with each network developing its own research questions and 
approach to dissemination. Compared with the six who did not participate, the two networks 
that were included were the two best positioned for a subcontracting relationship with the 
University of Kentucky in the time needed to complete the scope of work within the federal 
sponsor's budget period. Additionally, both networks had clear champions and expertise 
parallel to the original RCPC team (including a relationship with a communication specialist 
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and public health researchers trained in evaluating dissemination projects), presenting the 
most viable dissemination partnerships for testing the feasibility of intervention 
dissemination. The Kentucky PBRN had previously been made aware of the 1-2-3 Pap 
intervention as adapted and “dissemination-ready” for the statewide audience. The NC 
PBRN had a local media producer and academic partner available to re-adapt the video. This 
strategy both maximized potential for dissemination success and afforded the research team 
the opportunity to evaluate and develop resources to guide future dissemination efforts.
The RCPC provided material and financial support to PBRN investigators (champions) to 
work in partnership with the RCPC and other dissemination partners (often “opinion 
leaders” within their domains of expertise) within their states to identify locally salient 
messages and evaluate the relevant knowledge, attitudes, and behavior influencing HPV 
vaccination uptake and adherence in their target populations. Each champion used 
segmentation techniques to identify key target audiences and elicited feedback from 
practitioners, who were critical to determining how to adapt and deliver the effective “1-2-3 
Pap” intervention to new audiences. Importantly, researchers could draw lessons from these 
partnerships in evaluating the feasibility of disseminating “1-2-3 Pap” to new audiences and 
implementing it in diverse contexts.
Identification of additional partners should be guided by experiences with 
variation in uptake—Research has established that health departments and clinical 
practices in which key opinion leaders state that they use novel interventions report greater 
use of recommended, evidence-based interventions relative to sites without opinion leaders 
(Rogers, 2010; Valente, 2010). Early interactions with local public health officials can affect 
the rate of diffusion and likelihood of their adoption of recommended practices (Mays et al., 
2013; Merrill, Carley, Orr, Jeon, & Storrick, 2012). Therefore, as discussed in the previous 
section, identifying intervention dissemination resources such as effective champions (i.e., 
lead partner investigators) and opinion leaders (e.g., health department educators) within 
potential partnering organizations can guide the selection of additional partners.
Concern 2: Identifying Intervention Adaptations
Although Kentucky (and to some extent, West Virginia) offered fertile ground to examine a 
centralized intervention design process for dissemination to populations with similarities to 
the initial target audience, the question remained whether the intervention could be 
distributed to a more diverse audience with “scalable efficiency” (Dearing, Maibach, & 
Buller, 2006). To do so required considering potential adaptations that would allow for local 
redevelopment and evaluation during the intervention design process.
Identify information critical to matching new audience needs—One of the most 
challenging aspects of disseminating the “1-2-3-Pap” intervention was identifying how to 
adapt it to new audiences. By identifying information that potential new audiences have 
identified as important, researchers can assess whether information included will be accurate 
and relevant to other potential audiences. Information that is not accurate or relevant for a 
different potential population, then, may be necessarily subject to change or substitution to 
maximize the potential success of dissemination to other populations. Alternatively, 
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researchers may propose design adaptations or design information that potential users may 
not know they might need or may not think to request.
Partnering with champions across three states interested in adapting the intervention to reach 
both similar and dissimilar audiences provided valuable lessons in designing “1-2-3 Pap” for 
dissemination. In working closely with our three partners, the RCPC team devoted extensive 
time and energy to message redesign considerations. All intervention researchers seeking to 
disseminate their work will confront the question of how to resolve the inevitable tension 
between fidelity to the original message design and the need for flexibility in adapting an 
intervention for use in new contexts. From an intervention developer's perspective, it was 
indeed difficult to “let go” of an intervention for a redesign or employ an adapted version 
that might not be fully tested, especially when the original intervention is a highly targeted 
message based on extensive formative work with a specific population, as was the case with 
“1-2-3 Pap.” However, as noted by Cohen et al. (2008), “The need to adapt does not indicate 
a poor intervention or an inexperienced research team; it is a common part of the 
[dissemination] research process” (p. S387). Thus, it is just as important to attend to 
considerations specific to the dissemination process as it is to understand the factors that 
influence the original intervention design. As Slater, Finnegan, and Madigan (2005) noted, 
these strategic adaptations create an important bridge between academic research and 
practice; dissemination strategies that include adaptations and channel changes also have the 
potential to increase the reach and effectiveness of the intervention.
We employed multiple strategies for dissemination to new audiences and potential channels 
(for details, see the appendix). In West Virginia, we maintained fidelity to the original 
intervention in an adapted implementation strategy (i.e., as a video designed for use in 
clinical and community practices to coincide with vaccine administration) while making 
minor adaptations to appropriately localize the script. This approach was appropriate 
because the West Virginia audience and immunization partner goals most closely fit with the 
audience and goals for the original intervention. In Kentucky and North Carolina the 
strategies differed. The Kentucky dissemination research plan was to determine whether 
content from the original intervention was compatible with the intervention's purpose for 
participating health departments. In contrast, North Carolina offered the opportunity to re-
adapt the intervention developed for a narrowly tailored population (Appalachian Kentucky) 
to suit additional populations and contexts not originally considered in the research design. 
These strategies required adaptations to the original intervention for dissemination purposes 
(see appendix).
Identify material that can be adapted for similar audiences—In preparation for 
dissemination, the research team centrally planned two adaptations of “1-2-3 Pap” that 
would be guided by formative research. The goal of this central planning was to create 
videos available for dissemination and implementation that would be low-risk, low-cost, and 
scalable. For example, these two adapted videos for use statewide in Kentucky and West 
Virginia were filmed at the same time to save studio time and costs. In addition, when 
writing the script for the video, meeting with our media team to draft the storyboard, and 
filming scenes with the actors, we often had to leave significant amounts of material “on the 
cutting room floor.” To the extent possible, we tried to keep track of that material and 
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archive it for future use. In the case of the original “1-2-3 Pap” video intervention, this 
“extra” material included b-roll (supplemental or alternative footage recorded during the 
original video shoot), script ideas that were too “general” or did not fit our particular 
audience, and graphics that were designed but never used. We also repeatedly filmed the 
same scenes and lines with multiple actresses/participants while we had studio time. 
(Ideally, for national distribution, a video intervention would film segments with women of 
different racial/ethnic backgrounds, with different clothing, and from different areas of the 
country.) In the process of examining the script, we also identified the sections of the script 
that were essential or “core” persuasive health messages closely tied theoretically and 
practically to the original message development goals. These core message segments were 
retested with new populations for “fit” and for minor changes in language. We also 
identified persuasive message components that could vary or could be modified to address 
different target audiences without losing the core persuasive health message. (For adaptation 
details, see the appendix.)
The adaptation for West Virginia was minor, with the WIN paying for editing costs to 
change the localizing elements of the original “1-2-3 Pap” video that were specific to 
Appalachian Kentucky to those appropriate to West Virginia. These changes meant that the 
original anchor spokesperson needed to return to the studio to refilm HPV vaccination, 
cervical cancer, and Pap testing statistics and information segments to be retargeted to West 
Virginia. The WIN's logo was added to the video. On the other hand, the adaptation for 
Kentucky was broader in scope. An important goal was to include a culturally diverse set of 
actors to make the video more culturally appropriate for statewide dissemination. Messages 
indicating that women had already received the first dose of the HPV vaccine were altered, 
and an explanation for why one would choose to receive the first (and second and third) 
dose of the vaccine was included to broaden the potential reach and utility of the video to 
nonvaccinated audiences. In both of these centrally planned adaptations, however, the core 
message segments of the video developed from formative research were held constant, as 
the formative research suggested that they were appropriate for a statewide Kentucky and 
broader Appalachian audience, including West Virginia.
Identify material that can be adapted for dissimilar audiences—To better 
understand how to effectively adapt “1-2-3 Pap” for dissimilar audiences, the RCPC 
partnered with the NC PBRN to establish an effective model for adapting the video. The NC 
PBRN shared Kentucky's interest in the structural drivers of organizational variation across 
its participating local health departments. After viewing the original “1-2-3 Pap” 
intervention, a group of NC public health practitioners recommended message content and 
delivery adaptations to improve salience for the state's audiences. These recommendations 
included adding local b-roll from regions around North Carolina, selecting local talent who 
reflected state demographics and audiences of interest, striking a more conversational tone, 
substituting a local narrative of a young woman who received a cervical dysplasia diagnosis 
due to HPV that required treatment, and shortening the video's length. The resulting 
adaptation, “One … Two … Three … Pap NC” was produced during a 3-month period, after 
which the NC PBRN sought feedback from the RCPC and National Coordinating Center 
investigators. The video then was further edited and disseminated via a YouTube link and 
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hard-copy DVDs to health departments in 33 participating counties or 28 health jurisdictions 
(including three multicounty districts).
Taken together, these dissemination models and state partnerships offered the opportunity 
for “1-2-3 Pap” to be translated from an evidence-based intervention with local effectiveness 
to a program with potential for message adaptation and scalability. The appendix 
summarizes these message adaptations. When the RCPC pursued partnerships with public 
health services and systems researchers (Vanderpool, Brownson et al., 2013), we found that 
public health PBRNs were natural partners for determining optimal pathways for 
disseminating the “1-2-3 Pap” video intervention through the public health system. 
However, the research team also realized that to succeed in national dissemination, we 
would need partners not only willing to develop and evaluate a more extensive adaptation of 
the intervention but also willing to consider flexible options for dissemination strategies for 
these adapted products (Berwick, 2003; Dusenbury, Brannigan, Hansen, Walsh, & Falco, 
2005).
Concern 3: Identifying Means for Reaching Potential Future Audiences
Although message designers often design for the execution of their health communication 
interventions in specific contexts, when considering broader dissemination, researchers also 
should consider additional channels that might be used to increase the reach of these 
interventions to other populations. Delivery channel concerns are particularly crucial in 
terms of potential threats to intervention fidelity that might be posed by adding or changing 
different delivery channels or media formats, such as repurposing an audio–video clip (e.g., 
a television spot) into an audio-only format (e.g., radio). Thus, to create effective health 
communication interventions for dissemination, communication researchers also must 
consider message design factors related to the delivery medium.
The WIN developed an intentional “1-2-3 Pap” dissemination plan for the adapted video that 
they commissioned. First, two RCPC investigators (including the lead author) gave an hour-
long presentation at the WIN annual meeting and answered questions from practitioners 
about how to communicate about HPV vaccination with patients of different age groups. As 
part of the presentation and conference registration, practitioners received a “1-2-3 Pap 
WVA” DVD for use in their practices. Second, since the presentation the WIN has 
continued to distribute videos to health care providers across West Virginia through various 
strategies, including announcing the availability of the video by e-mail communication to 
coalition members and partners, sending newsletters identifying the video availability in 
DVD form and mailings of the DVD, distributing the DVD at state health conferences, and 
having other health associations (including the WV Nurses Association, the WV School-
Based Health Assembly, the Rural Health Association, the WV Chapter of the American 
Academy of Pediatrics, and the Mountains of Hope Cancer Coalition) communicate the 
video's availability to their members. To date, more than 300 “1-2-3 Pap” DVDs have been 
distributed to partners (an additional 300 have been ordered), including local health 
departments, community health centers, schools, free clinics, school-based and private 
health clinics, rural health centers, and hospitals.
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In contrast, in Kentucky, the KPHReN, the National Coordinating Center, and RCPC 
investigators recruited local health departments through a presentation at a monthly meeting 
of the Kentucky Health Department Association (KHDA) to engage in a funded pilot study 
evaluating different implementation approaches. This venue for recruiting local health 
departments (LHDs) was appropriate given the Brownson et al. (2013) findings that health 
department personnel often learn about research findings through professional associations. 
Of the 18 LHDs in Kentucky that chose to participate, two chose the replication of the 
original study in which patients viewed the video in the clinic immediately following receipt 
of the first HPV vaccine dose, 13 chose to provide access to the video online through either 
the health department's website/social media pages or its YouTube channel, and three 
elected to play the video on a loop in the health department waiting room or lobby for all 
patrons to view.
A similar approach was taken in North Carolina. NC LHDs were recruited through an 
announcement at the state health department conference. The recruitment announcement 
was made by a prominent LHD director, who was also 2013 LHD Director of the Year, and 
accompanied by a fact sheet. Researchers sent three follow-up e-mails to LHD directors via 
the LHD director listserv. Out of the 34 health jurisdictions (36 counties) that originally 
agreed to participate, 28 (33 counties) ultimately participated in the dissemination research 
study: 14 self-selected into the clinic setting, 12 chose the website/social media/YouTube 
channel route, and seven chose the lobby delivery location.
One lesson to draw from these different cases is that it is incumbent on researchers to 
determine the potential channels that are appropriate modalities for implementation and to 
be open to what potential partners believe are effective channels for these new audiences. In 
the case of “1-2-3 Pap Kentucky” and “One … Two … Three … Pap NC” the research team 
defined the potential channels and then the local health departments self-selected among 
three specific delivery channels. That is, the video could be delivered via multiple 
modalities: on a clinic iPad or a clinic computer (whichever was appropriate), on a loop in a 
waiting room, or even shared on YouTube, social media, or on the clinic's website. In the 
West Virginia context, we maintained fidelity to the DVD-based dissemination approach, 
and practitioners could implement the video intervention for clinical use as they saw fit. 
Research partnerships, then, must balance opportunities for partner creativity and 
adaptations with use of appropriate delivery channels as determined by the intervention 
developer. The appendix summarizes the message and channel considerations.
DESIGNING FOR DISSEMINATION: LESSONS LEARNED FROM “1-2-3 PAP”
Based on our experience with disseminating the “1-2-3-Pap” intervention, we conclude by 
presenting recommendations for others working in applied health communication 
intervention design to design for dissemination. The lessons we learned in disseminating this 
intervention to other audiences centered on three main areas: (a) identifying potential 
dissemination partnerships for reaching audiences for secondary dissemination, (b) 
determining necessary message design modifications, and (c) identifying appropriate 
channels for delivery that may differ from the original intervention. All of these concerns 
can and should be addressed early in the intervention design process. Certainly these steps 
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might take extra time; however, researchers should consider that they are not much different 
from the steps taken in developing the intervention for the primary audience. In fact, 
effective health communication intervention research without effective dissemination is like 
planting seeds without watering them; the intended change will never take root. Here, we 
summarize our experiences in disseminating “1-2-3 Pap” and leave the reader with some 
suggestions for designing for dissemination.
First, researchers should be attentive to opportunities to enhance demand for evidence-based 
interventions. One way to enhance demand for an intervention is to adapt it to different 
audiences. As a first step in dissemination of an evidence-based intervention with a clear 
target audience, the RCPC used planned strategies to increase usage of the “1-2-3 Pap” 
DVD in clinics within the target population. Although the intervention could be reproduced 
in a clinical setting with high fidelity, the message strategy itself was limited to its target 
audience of women receiving the first dose of the HPV vaccine. However, we realized that 
with very little effort, we could adapt the video and its messages to broader audiences. For 
example, we discovered that with minimal editing, the video could be generalized to gain 
relevance for women who had not yet received the first dose of vaccine.
A second way to enhance demand is by publicizing the intervention to appropriate decision 
makers and potential partners. Social marketing and diffusion principles can be adopted to 
ensure effective dissemination of an evidence-based intervention after initial execution. For 
example, in the case of “1-2-3 Pap,” we sought continued publicity for the original 
intervention to help enhance demand. As such, “1-2-3 Pap” was featured during National 
Immunization Awareness month (August 2013) as an effective intervention by the CDC on 
their website (http://www.cdc.gov/Features/hpvvaccinations/index.html). Additionally, to 
increase interest among others who may want to employ our approach to designing and 
disseminating health communication interventions, the RCPC research team participated in a 
nationally broadcast webinar sponsored by the CDC's Prevention Research Centers Program 
Office in March 2014. During the webinar, research team members were able to share the 
story of “1-2-3 Pap” as an intervention developed to improve adherence to the HPV 
vaccination protocol, increase awareness of the intervention's success, and encourage future 
dissemination partnerships.
Third, researchers should be open to adapting and extending intervention messages to new 
audiences. To do so may require that researchers develop messages in consideration of all 
partners who might be necessary to ensure successful secondary dissemination into practice 
contexts. Identifying potential new audiences and partnerships for message dissemination is 
a critical first step toward this end. Often researchers work within academic organizations 
with few reward structures or incentives for dissemination; however, researchers may 
partner with organizations such as PBRNs, which are well suited to assist. Importantly, 
researchers with experience in evaluating the effectiveness of randomized controlled 
intervention trials and other programs may lack expertise to disseminate programs and 
evaluate the effectiveness of the dissemination and implementation process. In recognition 
of this limitation, NIH has sponsored the Training Institute for Dissemination and 
Implementation Research in Health series to bring together researchers to discuss scientific 
strategies to improve dissemination and implementation science (Rabin et al., 2008).
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In planning for dissemination, it is important to acknowledge many barriers. Early on, we 
identified that primary care providers, local health departments, and other organizations may 
have differing views of whether and how this video-based intervention should be adopted. 
One clear lesson that was reaffirmed in this process was the importance of taking a 
participatory approach to involving research champions and their partners in all aspects of 
the dissemination process. Indeed, in both North Carolina and Kentucky, champions were 
able to maximize the potential number of interested research partnerships by allowing 
partners to self-identify appropriate channels for adoption of the intervention appropriate to 
their specific organizational context and population. Clearly, there are many barriers to 
successful dissemination partnerships that are not fully addressed by this case study, 
including conflicting mandates, funding limitations, workforce capacity issues, doubts about 
intervention implementation efficacy, and cost concerns. However, many of these barriers 
may be identifiable and surmountable if researchers consider potential dissemination 
partnerships during formative development stages. Identifying and communicating with 
potential champions and their partners early, engaging them as stakeholders in the initial 
intervention development, and partnering with existing networks and centers can enhance 
the viability of dissemination activities. Potential dissemination champions and partnerships 
contexts are numerous; they may include public schools, colleges and universities, 
workplace wellness initiatives, health and advocacy organizations, public health 
departments, clinical practice groups, media partners, and other stakeholders engaged with 
the health issue at hand.
Fourth, researchers should design messages for scalable adaptation. This design approach is 
consistent with the social marketing literature indicating the importance of developing 
appropriate packaging of intervention materials and testing them with potential partners 
through different means. As we noted, researchers may address this second concern of 
“adaptability” by identifying modifiable message components for future repackaging to 
other audiences. Researchers also should identify localizable components; for example, 
partners can help locate statistics, sources (e.g., a recognizable actor known to the target 
population), local graphics, visual images, and b-roll to assist researchers in adapting an 
intervention for dissemination. The main point is that researchers should consider which 
original messages elements can be adapted to reach new audiences and then work to show 
potential partners how these messages could be adapted to fit the needs of the new audience.
CONCLUSION
The aim of our article was to illuminate effective strategies for health communication 
scholars disseminating evidence-based interventions to secondary audiences. The “1-2-3 
Pap” intervention provides a clear case of how a highly targeted evidence-based intervention 
can subsequently be disseminated to different audiences and contexts. To enhance the reach 
and effectiveness of interventions designed for dissemination, health communication 
scholars involved in developing interventions must build dissemination strategies into their 
research designs. To do so requires careful planning and partnership development early in 
the intervention and message design process. One important lesson we learned is that there 
is an unavoidable tension between maintaining intervention fidelity and adapting 
interventions to be relevant to other audiences. We offer this lesson not to discourage others 
Cohen et al. Page 13
Health Commun. Author manuscript; available in PMC 2016 February 15.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
from working to disseminate their interventions to different audiences, but to encourage 
them to acknowledge this tension and to develop a strategy for addressing it early on in 
order to extend the reach and potential effectiveness of a carefully planned and developed 
intervention.
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Appendix
APPENDIX
REDESIGN CONSIDERATIONS FOR “1-2-3 PAP” DISSEMINATION TO NEW 
AUDIENCES
Original “1-2-3 Pap” intervention 
(Eastern Kentucky)
Kentucky (Statewide) West Virginia North Carolina
User: Organization or entity delivering the intervention
University of Kentucky Rural Cancer 
Prevention Center (RCPC)
Kentucky Public Health 
Research Network 
(KePHRN), identified 
through National 
Coordinating Center PBRN 
meeting
West Virginia 
Immunization 
Network (WVIN), 
identified through 
interpersonal 
networking and 
“1-2-3 Pap” paper 
presentation at the 
WVIN annual 
conference
North Carolina Public 
Health Practice-based 
Research Network 
(NC PBRN), 
identified through 
National Coordinating 
Center PBRN meeting
Context for dissemination: Specifically, the different types of support for dissemination of the intervention
Funding support — Additional funding 
support from 
WVIN
—
RCPC
Message/video design support — — Additional message 
(re)design support 
from NC PBRN and 
East Carolina 
University health 
communication 
partners
RCPC
Logistical support (e.g., coordinating 
talent and resources for filming, 
identifying practice partners, 
distributing video, etc.)
Additional logistical support 
from KePHRN
Additional 
logistical support 
from WVIN
Additional logistical 
support from NC 
PBRN
RCPC
Source: Talent used in video
Role: Moderator — — —
Talent type: Local Appalachian KY 
news anchor
— — Talent type: Replaced 
with a North Carolina 
public news anchor
Role: Health educator to deliver the 
educational messages
— — —
Talent type: Local Appalachian KY 
nurse
Talent type: Added Western 
KY health educator
Talent type: 
Retained Western 
Talent type: 
Substituted local 
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Original “1-2-3 Pap” intervention 
(Eastern Kentucky)
Kentucky (Statewide) West Virginia North Carolina
KY health educator 
and local 
Appalachian KY 
nurse from “1-2-3 
Pap” Kentucky 
version
North Carolina nurse 
for local Eastern KY 
nurse
Role: Patient models for young adult 
HPV vaccination
— — —
Talent type: Local Appalachian KY 
young women (selected from target 
population)
Talent type: Added young 
female actors to represent a 
broader, more diverse KY 
population
Talent type: 
Retained broader 
young female 
actors from “1-2-3 
Pap” Kentucky 
version who also 
represented a 
broader, more 
diverse WV 
population
Talent type: 
Substituted young 
female actors to 
represent a broader, 
more diverse NC 
population
Role: Granddaughter of cervical 
cancer victim
— — Role: Substituted an 
adult cervical cancer 
survivor
Talent type: Local Appalachian KY 
female storyteller depicting a “cancer 
burden narrative” on the importance 
of HPV vaccination for primary 
prevention to reduce the burden of 
cervical cancer in her community
— — Talent type: Local NC 
female storyteller 
depicting a “cancer 
burden narrative” on 
the importance of 
HPV vaccination for 
primary prevention to 
reduce the burden of 
cervical cancer in her 
community
Content of messages
Statistics and graphics
Targeted to Eastern KY audience 
demographics and psychographics
Modified statistics and 
graphics to retarget to entire 
KY population
Modified statistics 
and graphics to 
retarget to entire 
WV population
Modified statistics and 
graphics to retarget to 
entire NC population
Educational messages
Targeted to audiences of young 
women in Eastern Kentucky who had 
already received dose 1; also included 
messages about risks of HPV and 
HPV-related harm, benefits of 
vaccination and Pap tests, necessity to 
complete the vaccine series, 
motivation to complete the vaccine 
series, enhanced self-efficacy for 
series completion, and information for 
overcoming obstacles to series 
completion
Replaced message about 
receiving doses 2 and 3 with 
a message promoting 
initiation of the HPV 
vaccine series (i.e., dose 1) 
today.
— Added a 
conversational style of 
message delivery to 
deliver shorter 
messages with 
identical cervical 
cancer prevention 
content
Cues to action
Recommended follow-up with 
healthcare provider to receive doses 2 
and 3 of the HPV vaccine and regular 
Pap tests
Replaced message about 
receiving doses 2 and 3 with 
a message promoting 
initiation of the HPV 
vaccine series (i.e., dose 1) 
today.
Retained cues to receive all 
three doses of the HPV 
vaccine series.
Retained cues to 
action modified in 
“1-2-3 Pap” 
Kentucky version.
Retained cues to 
action modified in 
“1-2-3 Pap” Kentucky 
version.
Medium: Delivery method and location/context where video was viewed
Eastern KY women received dose 1 
of the HPV vaccine series at a clinic 
or health fair and then were 
randomized to receive the DVD 
intervention or usual care follow-up.
KePHRN offered local 
health departments (n = 18) 
three delivery method 
options:
WVIN provided 
video distribution 
and did not control 
the delivery 
method. Practices 
and providers 
NC PBRN offered 
local health 
departments (n = 28 
jurisdictions, 33 
counties) the three 
delivery method 
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Original “1-2-3 Pap” intervention 
(Eastern Kentucky)
Kentucky (Statewide) West Virginia North Carolina
(1) screening the video in 
their clinics (mirroring 
original delivery method);
(2) playing the video on a 
loop in the health 
department lobby or waiting 
room; and
(3) posting a video to health 
department websites and 
directing traffic to the 
website via printed 
materials, social media, and 
interpersonal 
communication.
reported screening 
the video in their 
clinics before and 
after dose 1 of the 
vaccine, and 
playing the video 
in a loop.
options provided in 
“1-2-3 Pap” Kentucky 
dissemination.
Note. Based on Green, Ottoson, Garcia, and Hiatt's (2009) knowledge dissemination framework; “—” means no changes 
were made to this part of the video for adaption to the new audience. Researchers worked with the partners to determine 
modifications. The goal of using these terms is to delineate the relationship between the adaptations and the original 
intervention, and each verb serves to describe the action taken by each implementing entity to adapt the original 
intervention (e.g., modify the intervention, replace elements of the intervention).
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